Skip to main content
. 2010 Nov 24;341:c6325. doi: 10.1136/bmj.c6325

Table 6.

 Ranked change scores of substance use at the four follow-up assessments (change from baseline in average amount per substance using day)

Control Therapy Increase in probability of improvement in therapy group*
n Abstinent or near abstinent Large decrease Small decrease Small increase Large increase n Abstinent or near abstinent Large decrease Small decrease Small increase Large increase
Main substance
6 months 143 12 (8.4) 24 (16.8) 42 (29.4) 16 (11.2) 49 (34.3) 142 13 (9.2) 26 (18.3) 49 (34.5) 21 (14.8) 33 (23.2) 14%
12 months 132 13 (9.8) 23 (17.4) 32 (24.2) 19 (14.4) 45 (34.1) 134 20 (14.9) 31 (23.1) 38 (28.4) 13 (9.7) 32 (23.9) 29%
18 months 125 22 (17.6) 19 (15.2) 30 (24.0) 11 (8.8) 43 (34.4) 125 26 (20.8) 28 (22.4) 34 (27.2) 6 (4.8) 31 (24.8) 24%
24 months 113 20 (17.7) 20 (17.7) 23 (20.4) 12 (10.6) 38 (33.6) 125 27 (21.6) 20 (16.0) 32 (25.6) 16 (12.8) 30 (24.0) 13%
Average 20%
All substances
6 months 148 8 (5.4) 21 (14.2) 43 (29.1) 21 (14.2) 55 (37.2) 143 8 (5.6) 21 (14.7) 47 (32.9) 27 (18.9) 40 (28.0) 9%
12 months 136 9 (6.6) 19 (14.0) 34 (25.0) 23 (16.9) 51 (37.5) 137 15 (10.9) 30 (21.9) 36 (26.3) 20 (14.6) 36 (26.3) 30%
18 months 128 16 (12.5) 20 (15.6) 31 (24.2) 14 (10.9) 47 (36.7) 127 18 (14.2) 25 (19.7) 39 (30.7) 9 (7.1) 36 (28.3) 23%
24 months 115 11 (9.6) 22 (19.1) 26 (22.6) 9 (7.8) 47 (40.9) 127 17 (13.4) 21 (16.5) 33 (26.0) 20 (15.7) 36 (28.3) 9%
Average 18%

All values are n (%). Abstinent or near abstinent: −100% to −80% change from baseline; Large decrease: −79% to −40% change from baseline; Small decrease: −39% to 0% change from baseline; Small increase: +1% to +20% change from baseline; Large increase: more than 20% change from baseline.

*Percentage increase in the proportion of participants who reduced substance use (“abstinent or near abstinent,” “large decrease,” and “small decrease” categories) in therapy group compared with controls.